Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.

Translated title of the contribution: Neoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.

J.B. Tuynman, C.J. Buskens, K. Kemper, F.J. ten Kate, G.J.A. Offerhaus, D.J. Richel, J.J. van Lanschot

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionNeoadjuvant selective COX-2 inhibition down-regulates important oncogenic pathways in patients with esophageal adenocarcinoma.
Original languageUndefined/Unknown
Pages (from-to)84084-84089
Number of pages6
JournalAnnals of Surgery
Volume242
Publication statusPublished - 2005

Keywords

  • Econometric and Statistical Methods: General
  • Geneeskunde (GENK)
  • Geneeskunde(GENK)
  • Algemeen onderzoek
  • Internal medicine

Cite this